Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 4OTHER 3NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 264Myeloid 100Lymphoid 51Gastrointestinal 11Classical hematology 7Head & Neck 6CNS 6Thoracic 5Sarcoma 5Plasma cell 5Dermatologic 5Breast 5Gynecologic 4Genitourinary 3Other solid neoplasm 2Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 2Pain 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Azacitidine × Genitourinary × Clear all
NCT03572387 2024-04-30

A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
14 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT00934440 2017-06-14

5-AZ

University of Kansas Medical Center

Phase 1/2 Terminated
11 enrolled 10 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00503984 2016-06-09

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

University of Miami

Phase 1/2 Terminated
22 enrolled 16 charts
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡